Journal article

The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting

James G Ryall, Gordon S Lynch

Pharmacology and Therapeutics | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2008

Grants

Awarded by Australian Research Council


Awarded by National Health and Medical Research Council of Australia


Awarded by Muscular Dystrophy Association (USA)


Funding Acknowledgements

The funding for this research has been provided by generous grants from the Australian Research Council Discovery-Project funding scheme (DP0665071, DP0772781), the National Health and Medical Research Council of Australia (350439, 454561, 509313), the Muscular Dystrophy Association (USA, 3595,4167), Pfizer Inc. (USA), and Merck & Co. Inc. (USA).